Advertisement
Loading...

argenx SE

ARGNF•PNK
Healthcare
Biotechnology
$803.19
$0.00(0.00%)
U.S. Market is Open • 15:41

argenx SE (ARGNF) Stock Overview

Explore argenx SE’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap49.7B
P/E Ratio22.82
EPS (TTM)$22.49
ROE0.34%
Fundamental Analysis

AI Price Forecasts

1 Month$841.14
3 Months$778.81
1 Year Target$887.72

ARGNF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of argenx SE (ARGNF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 56.57, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $887.72.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 22.82 and a market capitalization of 49.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-10.23%
3-Month Change
-1.44%
6-Month Change
-7.68%
Year-to-Date (YTD) Change
-7.68%
1-Year Change
42.92%
3-Year Change
102.15%
5-Year Change
152.28%
All-Time (Max) Change
7759.002%

Contact Information

https://www.argenx.com
31 10 703 8441
Willemstraat 5, Breda, NaN, 4811 AH

Company Facts

1,599 Employees
IPO DateApr 30, 2015
CountryNL
Actively Trading

Frequently Asked Questions